Oltmann Siemens, Famed International Banker and Economic Counselor, Joins C-MCC Development Group, LLC as Vice Chairman
The former representative of the World Bank brings a unique perspective to the Company's major trade and financial initiative in Curacao
NEW YORK, Oct. 12, 2017 (GLOBE NEWSWIRE) -- The C-MCC Development Group have announced that Oltmann Siemens, the eminent Jurist, Banker and Economic Counselor to many countries, has joined the company as Vice Chairman.
The C-MCC Development Group LLC, which is based in the U.S. and Curacao, has extensive experience in real estate development, technology, security and international commodities trading. It is the holding company of the Curacao Multi-Commodities Centre Worldwide Free Trade Zone, the first of its kind in the Western hemisphere. It will establish Curacao as a premier international trade development hub and gateway to the world's markets.
In making the announcement today, George Kearns, Chairman and CEO of C-MCC said, Oltmann Siemens has helped shape today's European business and financial interaction. "His achievements are inspiring and his interaction with governments and international business banking will add considerably to our endeavors to make Curacao the epicenter of trade and finance in this Hemisphere."
"His experience over several years in working with a number of governments including that of the U.S., together with international business and financial leaders, will help C-MCC identify the opportunities which lie ahead. He is a valuable asset to us in today's volatile global economic environment. We are privileged to have him join us."
The Chairman's comments were echoed by Dr. I. S. Steven Martina, Curacao's Minister of Economic Development, who said, Oltmann Siemens reputation precedes him. "My Government is intent on bringing international investment to Curacao, so for this and so many other reasons, we are delighted Oltmann has agreed to join the Board of C-MCC Development Group as its Vice Chairman. His unique worldwide perspective as a preeminent Jurist and International Banker, together with his interaction with world business leaders, will help accelerate the efforts of C-MCC and my government to place Curacao at the very forefront of regional trade and financial services."
In thanking the Minister and Chairman, George Kearns, Mr. Siemens said, "I am honored to have this opportunity to play a strategic role within a thoroughly aware and forward looking company like the C-MCC. We conduct our business in a world of seemingly instantaneous communication. The management of C-MCC, in their endeavors to create a dynamic all encompassing trade and distributive centre in Curacao, has embraced some of the most highly developed communications and trading tools to create an engine to provide a common regulatory global market and boost trade for the benefit of all. I admire this greatly and I am so very pleased to join them in establishing Curacao as a premier financial centre in the Western Hemisphere - one that will revolutionize business and economic growth in the region. Again, I am so very pleased to join this group of dedicated business leaders."
C-MCC Worldwide is a free trade zone initiative that will provide an ecosystem to facilitate physical, commodity trading, financial, technological and regulatory services through Curacao. It is the first free zone entity of its kind in the western hemisphere that will establish Curacao as the premier international trade development hub and gateway to the world. The establishment of the C-MCC will reduce political and economic risk and revolutionize the growth of trade, business and communities in many regions of the world.
|Christina Sitlani, Director Marketing||Victor Webb|
|C-MCC Worldwide||Marston Webb International|
|T: (347) 529-9344||T: (212) 684-6601|
|e-mail: Christina.Sitlani@c-mcc.com||e-mail: email@example.com|
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: C-MCC Development Group, LLC via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 201817.7.2018 22:30 | Pressmeddelande
LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the meeting, all resolutions for which management recommended a vote in favor, were adopted, including: - Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2017 and quietus of directors; - Allocation of the financial year's results; - Approval of regulatory agreements and commitments referred to in Article L.225-38 of the French Commercial Code; - Approval of the regulations of the share subscription and/or purchase options plan adopted by the Board of Directors on June 27, 2017; - Authorization for the Board of Directors to grant share subscription and/or share purchase options and/or to issue detachable share subscription warrants to corporate officers and employees of the Company or companies in the ERYTECH Pharma
Williams Scotsman Receives Competition Bureau Clearance for ModSpace Acquisition17.7.2018 22:15 | Pressmeddelande
BALTIMORE, July 17, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (NASDAQ:WSC) ("Williams Scotsman"), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that, on July 16, 2018, the Canadian Competition Bureau issued a No Action Letter relating to Williams Scotsman's proposed acquisition of Modular Space Corporation ("ModSpace"). WillScot has now obtained the regulatory approvals required to complete the acquisition and continues to progress towards closing in the third quarter of 2018. About Williams Scotsman Headquartered in Baltimore, Maryland, WillScot Corporation is the public holding company for the Williams Scotsman family of companies in the United States, Canada and Mexico. WillScot Corporation trades on the NASDAQ stock exchange under the ticker symbol "WSC." Williams Scotsman is a specialty rental services market leader providing innovative modular space and portable storage solutio
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors17.7.2018 22:05 | Pressmeddelande
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the election of Jeryl Hilleman to the Board of Directors of the Company. "Jeri brings a broad life sciences background to Minerva that includes high growth commercial biopharma, med-tech and data science companies," said William F. Doyle, Lead Independent Director of Minerva. "Her track record of delivering strategic and financial growth through execution, strategic partnering and multiple acquisitions will serve Minerva well as the Company completes five ongoing late-stage clinical trials with roluperidone, seltorexant and MIN-117." Ms. Hilleman is presently Chief Financial Officer of Intersect ENT (NASDAQ:XENT), a medical device company with commercial products for the treatment of chronic sinusitis. Previously, she served as CFO of several public
Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide17.7.2018 21:00 | Pressmeddelande
OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a grant of $2M US dollars by the National Center for Research and Development . The grant will fund a project to advance development of the company's innovative microbicide candidate (OB-002H). Designed to prevent the transmission of HIV, OB-002H has the potential to address an urgent and growing need for an HIV prevention product that is affordable, appealing to use, and easily integrates into the lifestyles of people at risk for HIV infection regardless of age, sex or gender. The project is co-financed by the National Center for Research and Development under the InnoNeuroPharm program - Measure 1.2: Sectoral R & D programs of the Intelligent Development Operational Program 2014-2020. Orion Biotechnology will use the grant to complete IND enabling studies, advance OB-002H to
Greater Anglia Selects PowerPlan to Optimise Its Asset Investments17.7.2018 15:29 | Pressmeddelande
ATLANTA, July 17, 2018 (GLOBE NEWSWIRE) -- Greater Anglia, a UK-based train operating company, has selected PowerPlan's Asset Investment Optimization software suite to maximise its asset investments over a 40-year time period. Greater Anglia's long-term investment strategy includes a 40-year asset plan to meet its regulatory requirements. For what was historically built with manual processes and not easily tracked, the Asset Investment Optimization solution from PowerPlan will provide a comprehensive, auditable approach to help the company analyze different investment scenarios for impacts to risk, cost, timing and level of service and provide a defendable asset plan for the next four decades. "The condition of our assets drives our business," said Richard Turner, Head of Asset Management for Greater Anglia. "With PowerPlan, we can apply a fact-based methodology to prioritise investments, maximise their return and produce plans that communicate our asset strategy to internal and extern
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 201817.7.2018 14:30 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 9268558, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com. The replay will be available on the Company's website for approximately
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum